Devon Herrick: FDA vs. Generic Drugs
The Heartland Institute: In an interview with The Heartland Institute, NCPA Senior Fellow Devon Herrick says some drug inflation is due to slow action by the FDA, which has a backlog of around 4,000 abbreviated new drug applications.